Sera Prognostics Profit Margin

The latest profit margin for SERA is -47475.71% as of June 2026. That compares with -30306.48% in the prior-year period — down 56.7% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Sera Prognostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SERA's profit margin moved from -30306.48% to -47475.71% — a 56.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sera Prognostics's valuation or profitability profile.

Against Healthcare companies, SERA currently prints -47475.71% for profit margin, while the sector average sits near 13.89%. That is roughly 341893.9% below the sector mean. Large gaps often invite a closer look at Sera Prognostics's growth, margins, and balance sheet.

Profit Margin shows how effectively Sera Prognostics converts resources into returns. At -47475.71%, SERA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -30306.48% in the prior-year period — down 56.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SERA's profit margin (-47475.71%), review year-over-year change from -30306.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.